Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Liver Cancer and Men

Genes play a big role.

Liver cancer kills more than twice as many men as women in the United States every year. MIT researchers have discovered that male genes are partly to blame for the disparity.

Arlin Rogers and his colleagues are looking into why men are likelier than women to develop liver cancer.

Arlin Rogers, chief of comparative pathology at MIT’s Division of Comparative Medicine, had theorized that sex hormones influenced the male liver’s susceptibility to tumors. In humans, the male liver receives intermittent bursts of growth hormone ­beginning at puberty. The same is true in mice, and male mice also develop liver cancer at higher rates than females.

This story is part of the May/June 2008 Issue of the MIT News Magazine
See the rest of the issue
Subscribe

Rogers and his colleagues infected mice with Helicobacter hepaticus, a bacterium that can cause liver tumors in rodents, much the way hepatitis B and C can in humans. They waited until the infected mice were middle-aged (one year old), because middle age is when liver damage in humans is often first detected. Then they castrated some males and gave others what Rogers calls a “whopping dose” of a powerful male sex hormone. Since previous studies have shown that mice castrated at puberty rarely develop liver cancer, Rogers expected that the castrated mice wouldn’t develop tumors and the hormonally charged ones would.

But to Rogers’s surprise, neither castration nor supplemental hormones affected the cancer risk of the mature mice. After much genetic analysis, his team discovered that the animals’ inflammatory response to infection was what caused cancer. Inflammation disrupted gene expression in the male liver, thus weakening the liver’s ability to process toxins and regulate cell growth; inappropriate cell growth can lead to cancer. Female livers are naturally more resistant to inflammation and respond better to it when it occurs.

Rogers hopes his group’s findings, recently published in the journal Cancer Research, will speed the discovery of biological targets for new therapies. “Already we have identified potential targets to preserve liver function and hopefully delay or prevent progression to cancer in high-risk patients of both sexes,” he says. “This will be the focus of future research in our laboratory and hopefully others.”

Tech Obsessive?
Become an Insider to get the story behind the story — and before anyone else.

Subscribe today
Next in MIT News
Want more award-winning journalism? Subscribe to Insider Online Only.
  • Insider Online Only {! insider.prices.online !}*

    {! insider.display.menuOptionsLabel !}

    Unlimited online access including articles and video, plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.